Angiotensin-Converting Enzyme Inhibitors in the Treatment of Mild Arterial Hypertension

References

• 1989 Guidelines for the management of mild hypertension: memorandum from a WHO/ISH Meeting. J Hypertens 1989; 7: 689–693
   PubMed Web of Science ®Google Scholar
• Williams GH. Converting-enzyme inhibitors in the treatment of hypertension. N Eng J Med 1989; 319: 1517–1525
   Web of Science ®Google Scholar
• Lee M AE, Paul M, Böhm M, Ganten D. Effects of angiotensin-converting enzyme inhibitors on tissue renin-angiotensin systems. Am J Cardiol 1992; 70: 12C–19C
   PubMedGoogle Scholar
• Romero JC, Ruilope LM, Bentley MD, Fiksen-Olsen MJ, Lahera V, Vidal M J. Comparison of the effects of calcim antagonists and converting enzyme inhibitors on renal function under normal and hypertensive conditions. Am J Cardiol 1988; 62: 59G–68G
   PubMedGoogle Scholar
• The treatment of Mild Hypertension Research Group. The treatment of Mild Hypertension Study. A randomized, placebo-controlled trial of a nutritional-hygienic regimen along with various drug monotherapies. Arch Intern Med 1991; 151: 1413–1423
   PubMed Web of Science ®Google Scholar
• Jenkins AC, Knill JR, Dreslinski G R. Captopril in the treatment of the elderly hypertensive patient. Arch Intern Med 1985; 145: 2029–2031
   PubMed Web of Science ®Google Scholar
• Muiesan G, Agabiti-Rosei E, Buoninconti R, et al. Antihypertensive efficacy and tolerability of captopril in the elderly: comparison with hydrochlorothiazide and placebo in a multicenter double-blind study. J Hypertens 1987; 5(suppl 5)S599–S602
   PubMedGoogle Scholar
• Rodicio JL, Alcazar JM, Ruilope L M. Influence of converting enzyme inhibition on glomerlar filtration rate and proteinuria. Kidney Int 1990; 38: 590–594
   PubMed Web of Science ®Google Scholar
• Veterans Administration Cooperative Study Group on Antihypertensive Agents. Low-dose captopril for the treatment of mild to moderate hypertension. I. Results of a 14-week trial. Arch Intern Med 1984; 144: 1947–1953
   PubMed Web of Science ®Google Scholar
• Sassano P, Chatellier G, Billaud E, Alhenc-Gelas F, Corvol P, Mènard J. Treatment of mild to moderate hypertension with or without the converting enzyme inhibitor enalapril: results of a six-month double blind trial. Am J Med 1987; 83: 227–235
   PubMed Web of Science ®Google Scholar
• White WB, Viadero JJ, Lane TJ, Podesla S. Effects of combination therapy with captopril and nifedipine in severe or resistant hypertension. Clin Pharmacol The 1986; 39: 43–48
   Google Scholar
• Singer D RJ, Markandu ND, Cappccio FP, MacGregor G A. Stdies of captopril alone and in combination with the benzothiazepine diltiazem and the dihydropiridine nifedipine in treating essential hypertension. J Cardiovasc Pharmacol 1991; 18(suppl 9)S51–S54
   PubMedGoogle Scholar
• Materson BJ. Adverse effects of angiotensin-converting enzyme inhibitors in antihypertensive therapy with focus on quinapril. Am J Cardiol 1992; 69: 46C–53C
   PubMed Web of Science ®Google Scholar
• Israili ZH, Hall W D. Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology. Ann Intern Med 1992; 117: 234–242
   PubMed Web of Science ®Google Scholar
• Sleight P. After the diagnosis of systemic hypertension, is risk factor management important?. Am J Cardiol 1992; 70: 9D–13D
   PubMedGoogle Scholar
• Ferrannini E, Natali A. Essential hypertension, metabolic disorders, and inslin resistance. Am Heart J 1991; 121: 1274–1282
   PubMed Web of Science ®Google Scholar
• Julius S, Jamerson K, Mejia A, Krause L, Schork N, Jones K. The association of borderline hypertension with target organ changes and higher coronary risk. JAMA 1990; 264: 354–358
   PubMed Web of Science ®Google Scholar
• Pollare T, Lithell H, Berne C. A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. N Engl J Med 1989; 321: 868–873
   PubMed Web of Science ®Google Scholar
• Ferrara LA, DiMarino L, Russo O, Marotta T, Mancini M. on behalf of the DoCHH Study Group. Doxazosin and captopril in mildly hyperdholesterolemic hypertensive patients: The doxazosin-captopril in hypercholesterolemic hypertensives study. Hypertension 1993; 21: 97–104
   PubMed Web of Science ®Google Scholar
• Dählof B, Pennert K, Hansson L. Regression of left ventricular hypertrophy. A meta-analysis. Clin Exp Hypertens (A) 1992; 14A: 173–180
   Google Scholar
• Mathiesen ER, Hommel E, Giese J, Parving H H. Efficacy of captopril in postponoing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria. Br Med J 1991; 303: 81–87
   PubMed Web of Science ®Google Scholar
• Deedwania PC. Angiotensin-converting enzyme inhibitors in congestive heart failure. Arch Intern Med 1990; 150: 1798–1805
   PubMed Web of Science ®Google Scholar
• Pfeffer MA, Braunwald E, Moyé L, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1992; 327: 669–677
   PubMed Web of Science ®Google Scholar
• Croog SH, Levine S, Testa MA, et al. The effects of antihypertensive therapy on the quality of life. N Eng J Med 1986; 314: 1657–1664
   PubMed Web of Science ®Google Scholar
• Hjemdahl P, Wiklund I K. Quality of life on antihypertensive drug therapy: scientific end-point or marketing exercise. J Hypertens 1992; 10: 1437–1446
   PubMed Web of Science ®Google Scholar
• Stason WB. Opportunities to improve the cost-effectiveness of treatment for hypertension. Hypertension 1991; 18: I161–I166
   PubMedGoogle Scholar
• Johannesson M, Fagerberg B. A health-economic comparison of diet and drug treatment in obese men with mild hypertension. J Hypertens 1992; 10: 1063–1070
   PubMed Web of Science ®Google Scholar
• Ramsay LE, Yeo WW, Jackson P R. Thiazide diuretics: first-line therapy for hypertension. J Hypertens 1992; 10(suppl 3)S29–S33
   PubMedGoogle Scholar